Welcome to our dedicated page for Agiliti news (Ticker: AGTI), a resource for investors and traders seeking the latest updates and insights on Agiliti stock.
This page contains historical news coverage for Agiliti Inc (AGTI), a healthcare equipment management company that was acquired by THL Partners and taken private. The company previously traded on the New York Stock Exchange before the acquisition transaction closed.
Agiliti operated as a medical equipment services provider, offering device rental, repair, maintenance, and lifecycle management to hospitals and healthcare systems throughout the United States. The company served as a partner to healthcare organizations seeking to optimize their medical equipment investments without the capital burden of outright ownership.
Browse this news archive to review coverage of Agiliti's business developments, financial announcements, and the events surrounding its transition to private ownership. Historical news includes quarterly earnings releases, strategic announcements, and investor communications from the company's years as a publicly traded entity. This archive provides context for understanding the company's operational history and the factors that shaped its trajectory leading to the acquisition.
For researchers and investors reviewing past positions, this collection of Agiliti news offers insight into the healthcare equipment services sector and how one of its significant players evolved over time. The news coverage documents the company's journey from public markets to private equity ownership.
Agiliti announced the retirement of
Agiliti Inc. (NYSE: AGTI) reported its Q3 2022 financial results, revealing a 3% revenue growth to $271 million. However, net income fell $7.7 million year-over-year, totaling $2 million, and diluted EPS decreased by $0.06 to $0.01. Adjusted EBITDA also declined by 18.9% to $66.5 million. Despite a 12.2% revenue increase for the nine months ended September 30, 2022, the company revised its full-year guidance to $1.11 - $1.12 billion in revenue and $290-300 million in adjusted EBITDA, reflecting a cautious outlook.
Agiliti Inc. (NYSE: AGTI) will release its third quarter results on November 10, 2022, after market close. A conference call will follow at 5 p.m. Eastern Time, where investors can join via phone or webcast. Agiliti provides essential services to the U.S. healthcare industry, supporting over 9,000 healthcare providers with solutions aimed at enhancing efficiency and patient outcomes. For more information, access details for the call and its replay are available through Agiliti's Investor Relations website.
Agiliti Inc. (AGTI) reported a 9% increase in revenue for Q2 2022, totaling $274 million. Net income rose to $5 million, reflecting a $10.2 million year-over-year increase. However, adjusted EBITDA decreased by 10.4% to $69.6 million. The company maintained its 2022 financial guidance with revenue expectations of $1.16 - $1.19 billion and adjusted EBITDA of $305 - $315 million, anticipating results at the lower end of the range. CEO Tom Leonard cited temporary challenges affecting financial results but expressed confidence in the company's ongoing business strength.
Agiliti Inc. (NYSE: AGTI) will announce its second quarter results on August 9, 2022, after market close, followed by a conference call at 5 p.m. Eastern Time. Interested parties can listen via phone at 1-877-407-0792 or internationally at 1-201-689-8263. A replay will be available two hours post-call until August 16, 2022. Agiliti provides essential services to the U.S. healthcare sector, managing medical equipment for over 9,000 providers, enhancing cost efficiency and patient outcomes.
Agiliti Inc. (NYSE: AGTI) reported Q1 2022 financial results, with revenue growth of 25.2% to $294.4 million and a net income of $19.9 million, up 108.2% from the prior year. Diluted earnings per share increased to $0.14, a rise of $0.05 year-over-year. Adjusted EBITDA reached $89.2 million, a 3.4% increase. The company reaffirmed its 2022 outlook, forecasting revenue between $1,160 - $1,190 million and adjusted earnings per share of $0.89 - $0.94. The total debt stands at $1,121 million with a net leverage ratio of 3.2x.
Agiliti Inc. (NYSE: AGTI) announced its participation in upcoming investor conferences. The BofA Securities Healthcare Conference will occur on May 11, 2022, with a fireside chat at 4:40 PM local time in Las Vegas. Additionally, Agiliti will participate in the UBS Global Healthcare Conference on May 24, 2022, with a chat at 4:15 PM local time in New York. Investors can listen to webcasts via the company’s Investor Relations website. Agiliti provides essential services to the U.S. healthcare sector, serving over 9,000 providers.
Agiliti Inc. (NYSE: AGTI) will release its first quarter results after market close on May 10, 2022. A conference call is scheduled for 5 p.m. Eastern Time, accessible via phone and webcast. The company provides essential services to the U.S. healthcare sector, serving over 9,000 healthcare providers and delivering solutions to enhance cost-efficiency and patient outcomes. The replay of the call will be available until May 17, 2022.
Agiliti Inc. (NYSE: AGTI) will participate in the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2022. The company is set to host 1x1 investor meetings and a fireside chat at 3 p.m. Eastern Time on the same day. Investors can access a live webcast of the fireside chat via the Investor Relations section on Agiliti's website. With over 80 years in the industry, Agiliti provides essential services to the U.S. healthcare sector, enhancing efficiency and supporting patient outcomes for over 9,000 healthcare providers nationwide.
Agiliti Inc. (NYSE: AGTI) reported a 36% revenue growth in Q4 2021, reaching $290 million, with net income of $10 million. Full-year revenue increased by 34% to $1.04 billion, driven by a strong performance in healthcare technology services. Adjusted EBITDA for Q4 grew 18% to $85 million, with a full-year total of $331 million, a 41% increase. The company expects 2022 revenue between $1.16 - $1.19 billion and adjusted EBITDA of $305-315 million. A new one-year agreement with the U.S. HHS for ventilator maintenance was also established, consolidating existing contracts.